These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 20458083)

  • 21. Proton pump inhibitors use and change in bone mineral density.
    Arj A; Razavi Zade M; Yavari M; Akbari H; Zamani B; Asemi Z
    Int J Rheum Dis; 2016 Sep; 19(9):864-8. PubMed ID: 27242025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary Inflammatory Index, Bone Mineral Density, and Risk of Fracture in Postmenopausal Women: Results From the Women's Health Initiative.
    Orchard T; Yildiz V; Steck SE; Hébert JR; Ma Y; Cauley JA; Li W; Mossavar-Rahmani Y; Johnson KC; Sattari M; LeBoff M; Wactawski-Wende J; Jackson RD
    J Bone Miner Res; 2017 May; 32(5):1136-1146. PubMed ID: 28019686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renin-angiotensin aldosterone system and osteoporosis: findings from the Women's Health Initiative.
    Carbone LD; Vasan S; Prentice RL; Harshfield G; Haring B; Cauley JA; Johnson KC
    Osteoporos Int; 2019 Oct; 30(10):2039-2056. PubMed ID: 31209511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of fracture discrimination using calcaneal quantitative ultrasound and dual X-ray absorptiometry in women with a history of fracture at sites other than the spine and hip.
    Frost ML; Blake GM; Fogelman I
    Calcif Tissue Int; 2002 Sep; 71(3):207-11. PubMed ID: 12154392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
    Leslie WD; Martineau P; Bryanton M; Lix LM
    Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study.
    Crandall CJ; Hovey KM; Cauley JA; Andrews CA; Curtis JR; Wactawski-Wende J; Wright NC; Li W; LeBoff MS
    J Bone Miner Res; 2015 Nov; 30(11):2086-95. PubMed ID: 25990562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fractal analysis of radiographic trabecular bone texture and bone mineral density: two complementary parameters related to osteoporotic fractures.
    Benhamou CL; Poupon S; Lespessailles E; Loiseau S; Jennane R; Siroux V; Ohley W; Pothuaud L
    J Bone Miner Res; 2001 Apr; 16(4):697-704. PubMed ID: 11315997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between Proton Pump Inhibitor and Histamine-2 Receptor Antagonist and Bone Mineral Density among Kidney Transplant Recipients.
    Lyu B; Hansen KE; Jorgenson MR; Astor BC
    Am J Nephrol; 2020; 51(6):433-441. PubMed ID: 32485707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.
    Cauley JA; Robbins J; Chen Z; Cummings SR; Jackson RD; LaCroix AZ; LeBoff M; Lewis CE; McGowan J; Neuner J; Pettinger M; Stefanick ML; Wactawski-Wende J; Watts NB;
    JAMA; 2003 Oct; 290(13):1729-38. PubMed ID: 14519707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline age and time to major fracture in younger postmenopausal women.
    Gourlay ML; Overman RA; Fine JP; Ensrud KE; Crandall CJ; Gass ML; Robbins J; Johnson KC; LeBlanc ES; Womack CR; Schousboe JT; LaCroix AZ;
    Menopause; 2015 Jun; 22(6):589-97. PubMed ID: 25349960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term proton pump inhibitor use and risk of osteoporosis and hip fractures: A nationwide population-based and multicenter cohort study using a common data model.
    Park DH; Seo SI; Lee KJ; Kim J; Kim Y; Seo WW; Lee HS; Shin WG; Yoo JJ
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1534-1543. PubMed ID: 35501296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esomeprazole use is independently associated with significant reduction of BMD: 1-year prospective comparative safety study of four proton pump inhibitors.
    Bahtiri E; Islami H; Hoxha R; Qorraj-Bytyqi H; Rexhepi S; Hoti K; Thaçi K; Thaçi S; Karakulak Ç
    J Bone Miner Metab; 2016 Sep; 34(5):571-9. PubMed ID: 26209167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of Subsequent Fractures in Postmenopausal Women After Nontraumatic vs Traumatic Fractures.
    Crandall CJ; Larson JC; LaCroix AZ; Robbins JA; Wactawski-Wende J; Johnson KC; Sattari M; Stone KL; Weitlauf JC; Gure TR; Cauley JA
    JAMA Intern Med; 2021 Aug; 181(8):1055-1063. PubMed ID: 34096979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study.
    Bonds DE; Larson JC; Schwartz AV; Strotmeyer ES; Robbins J; Rodriguez BL; Johnson KC; Margolis KL
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3404-10. PubMed ID: 16804043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. beta-Blocker use, BMD, and fractures in the study of osteoporotic fractures.
    Reid IR; Gamble GD; Grey AB; Black DM; Ensrud KE; Browner WS; Bauer DC
    J Bone Miner Res; 2005 Apr; 20(4):613-8. PubMed ID: 15765180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitors and fracture risk. The HUNT study, Norway.
    Hoff M; Skovlund E; Skurtveit S; Meyer HE; Langhammer A; Søgaard AJ; Syversen U; Forsmo S; Abrahamsen B; Schei B
    Osteoporos Int; 2020 Jan; 31(1):109-118. PubMed ID: 31741023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between incidence of fractures and anemia in older multiethnic women.
    Chen Z; Thomson CA; Aickin M; Nicholas JS; Van Wyck D; Lewis CE; Cauley JA; Bassford T;
    J Am Geriatr Soc; 2010 Dec; 58(12):2337-44. PubMed ID: 21143442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticholinergic Medication Use and Fractures in Postmenopausal Women: Findings from the Women's Health Initiative.
    Marcum ZA; Wirtz HS; Pettinger M; LaCroix AZ; Carnahan R; Cauley JA; Bea JW; Gray SL
    Drugs Aging; 2015 Sep; 32(9):755-63. PubMed ID: 26373414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.